Streetbeat News

Stock Prices

EYEN

Eyenovia (NASDAQ:EYEN) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.17. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $2.06 and has seen a 25.6% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:02 pm

APDN

Applied DNA Sciences (NASDAQ:APDN) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.24. The company's past performance shows a mixed impact on the share price post-earnings release. The stock is currently trading at $1.55, down 65.71% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm

IDN

Intellicheck (NASDAQ:IDN) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.05. The company's past performance shows a pattern of share price changes following earnings reports. Shares of Intellicheck were trading at $2.6 as of August 08, with a 5.77% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm

ZLAB

Zai Lab's stock is trading higher, rebounding after a fall on Tuesday.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 6:01 pm

BIOL

Biolase (NASDAQ:BIOL) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-5.33. The company's past performance shows a pattern of share price drops following earnings reports. Shares of Biolase were trading at $6.79 as of August 08, with a 98.8% decrease over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm

ILLM

illumin Holdings Inc (NASDAQ: ILLM) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.03. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $1.79, down 37.28% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm

XELB

Xcel Brands (NASDAQ:XELB) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.13. The company's past performance shows a trend of missing EPS estimates, which has led to share price drops. However, the stock has seen a 43.09% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm

RELI

Reliance Global Group (NASDAQ:RELI) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.70. The company's past performance shows a pattern of share price drops following earnings reports. The stock is currently trading at $3.28, down 75.96% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm

KOPN

Kopin (NASDAQ:KOPN) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.02. The company's past performance shows a mixed trend of meeting or missing EPS estimates, with corresponding changes in share price. Shares of Kopin were trading at $1.76 as of August 08, with a 52-week increase of 17.21%.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm

INZY

Over the past 3 months, 4 analysts have published bullish opinions on Inozyme Pharma (NASDAQ:INZY) stock, with an average 12-month price target of $19.5, an increase of 2.63% from the previous average price target of $19.00.

Portfolio Pulse from Benzinga Insights

August 09, 2023 | 6:01 pm